Penile cancers associated with occurrence of other neoplasms
Authors:
E. Geryk; D. Pacík; J. Kozel; A. Čermák
Published in:
Urol List 2012; 10(4): 6-11
Overview
A total of 1,565 penile cancers (PeC), based in the Czech Cancer Registry in 1976–2005, there were notificated 280 (17.9%) their multiple cases. Of them in 155 males with primary PeC followed 165 other neoplasms and in 125 males with subsequent PeC preceded 169 other neoplasms. The number of primary PeC incerased unstable till 1997 and then decreased, of subsequent PeC increased till 2005. A total of 14 Czech regions were distributed 42.5% multiple PeC in four regions (Prague, Southern Bohemia, Northern and Southern Moravia). Of primary PeC were registered 23.2% cases at the early, 2.6% advanced and 74.2% unknown clinical stages; respectively 41.6% and 17.6% and 40.8% in subsequent PeC. A total of 165 subsequent neoplasms (including 29 synchronous cases) after PeC were 31 cancers of skin, 40 digestive, 31 urogenital and 25 respiratory system, of which were 26.1% cases at the early, 22.4% at advanced and 51.5% at unknown stages. A total of 169 other primary neoplasms, before subsequent PeC were 71 cancers of skin, 44 urogenital system and 20 colorectum. Up to October 2007 survived one-fifth of males with primary PeC and one-third of subsequent PeC. In a view of processed data of the most multiple cancer diagnoses the Czech medical surveillance seems insufficient. The incidence of subsequent advanced stages must be prevented by updating guidelines and screening of the most frequent neoplasms.
Key words:
penile cancer - multiple occurrence- distribution by age, time, spacesynchronous and metachronous neoplasms - clinical stages
Sources
1. ÚZIS. Novotvary 2009 ČR. Praha: ÚZIS ČR, 2012: 264, www.uzis.cz.
2. McMaster M, Feuer EJ, Tucker MA. New malignancies following cancer of the male genital tract. In: Curtis RE at al. New malignancies among cancer survivors: SEER cancer registries 1973–2000. Bethesda (MD), Nat Canc Inst 2006; 257–284.
3. Brinton LA, Li JY, Rong SD et al. Risk factors for penile cancer: results from a case-control study in China. Int J Cancer 1991; 47(4): 504–509.
4. Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. N Engl J Med 1990; 322(16): 1093–1097.
5. Tseng HF, Morgenstern H, Mack T et al. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (US). Cancer Causes Control 2001; 12(3): 267–277.
6. Geryk E, Dítě P, Kozel J et al. Nádorové multiplicity u české populace. Čas Lék Čes 2010; 149(4): 178–183.
7. Herrero R, Castellsague X, Pawlita M et al. Human papilomavirus and oral cancer: the International Agency for Research on Cancer multi-center study. J Natl Cancer Inst 2003; 95(23): 1772–1783.
8. Peters RK, Mack TM, Bernstein L. Parallels in the epidemiology of selected anogenital carcinomas. J Natl Cancer Inst 1984; 72(3): 609–615.
9. Daling JR, Madeleine MM, Johnson LG et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101(2): 270–280.
10. Machalek DA, Poynten M, Jin F et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13(5): 487–500.
11. Geryk E, Pacík D, Čermák A et al. Další primární novotvary u nemocných s karcinomem prostaty ve srovnání s jeho incidencí, mortalitou a prevalencí. Onkologie 2010; 4(2): 89–93.
12. Geryk E, Kozel J, Pacík D et al. Vícečetné nádory testis. Urol pro prax 2013(1): v tisku.
13. Engholm G, Ferlay J, Christensen N et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010; 49(5): 725–736.
14. Engholm G, Ferlay J, Christensen N et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 5.1 Association of the Nordic Cancer Registries. Danish Cancer Society, 2012, Available: http://www.ancr.nu, accessed on day/month/year.
15. Geryk E, Landys K, Persson G et al. Švédský onkologický registr. Klin Onkol 1996; 5: 163–166.
16. Bermejo JL, Hemminki K. Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst 2005; 97(21): 1575–1579.
17. Štampach R, Kubíček P, Geryk E et al. Health statistics in international databases and their cartographic visualisation. Questiones Geographicae 2012; 31(3): 77–88.
18. Geryk E, Pacík D, Čermák A. Nádory prostaty a varlat u české a světové populace. Urol List 2012; 10(1): 19–25.
19. http://www.linkos.cz/.
20. Curado WMP, Edwards B, Shin HR et al (eds). Cancer Incidence in Five Continents. Vol. IX, IARC Scientific Publication No. 160, 2008; 897.
Labels
Paediatric urologist UrologyArticle was published in
Urological Journal
2012 Issue 4
Most read in this issue
- Adverse events of hormone replacement testosterone therapy
- Testicular adenomatoid tumor – diagnosis and operating procedures
- Vaporizace prostaty pomocí zeleného laseru (GreenLight laser) – zkušenost z jednoho centra po provedení více než 1 000 výkonů
- Development of surgical retrieval a men's sperm with azoospemia